Enantiomerically Pure Thrombin Inhibitors for Exploring the Molecular-Recognition Features of the Oxyanion Hole
暂无分享,去创建一个
F. Diederich | D. Banner | M. Morgenthaler | P. Seiler | U. Obst‐Sander | T. Tschopp | Kaspar Schaerer
[1] Manfred Kansy,et al. Fluorine Interactions at the Thrombin Active Site: Protein Backbone Fragments HCαCO Comprise a Favorable CF Environment and Interactions of CF with Electrophiles , 2004, Chembiochem : a European journal of chemical biology.
[2] F. Diederich,et al. A fluorine scan of the phenylamidinium needle of tricyclic thrombin inhibitors: effects of fluorine substitution on pKa and binding affinity and evidence for intermolecular C-F...CN interactions. , 2004, Organic & biomolecular chemistry.
[3] G. Gilliland,et al. Crystal structure of the complex between thrombin and the central "E" region of fibrin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[4] F. Diederich,et al. Medicinal chemistry in academia: molecular recognition with biological receptors. , 2004, Chemical communications.
[5] D. Musil,et al. Synthesis and SAR of thrombin inhibitors incorporating a novel 4-amino-morpholinone sscaffold: analysis of X-ray crystal structure of enzyme inhibitor complex. , 2003, Journal of medicinal chemistry.
[6] C. Park,et al. Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d-diphenylalanyl-l-prolyl[(5-amidino-2-thienyl)methyl]amide. , 2003, Journal of medicinal chemistry.
[7] W. M. Sanders,et al. Azaindoles: moderately basic P1 groups for enhancing the selectivity of thrombin inhibitors. , 2003, Bioorganic & medicinal chemistry letters.
[8] Stephen Hanessian,et al. Targeting thrombin and factor VIIa: design, synthesis, and inhibitory activity of functionally relevant indolizidinones. , 2002, Bioorganic & medicinal chemistry letters.
[9] F. Diederich,et al. Structure‐Based Design of Nonpeptidic Thrombin Inhibitors: Exploring the D‐Pocket and the Oxyanion Hole , 2002 .
[10] P. Winocour,et al. Novel bicyclic lactam inhibitors of thrombin: highly potent and selective inhibitors. , 2002, Bioorganic & medicinal chemistry letters.
[11] H. Nar,et al. Structure-based design of novel potent nonpeptide thrombin inhibitors. , 2002, Journal of medicinal chemistry.
[12] J. Ho,et al. Novel, potent non-covalent thrombin inhibitors incorporating p(3)-lactam scaffolds. , 2002, Bioorganic & medicinal chemistry letters.
[13] J. Rubin,et al. Novel bicyclic lactam inhibitors of thrombin: potency and selectivity optimization through P1 residues. , 2001, Bioorganic & medicinal chemistry letters.
[14] K. Eagen,et al. Potent, low molecular weight thrombin receptor antagonists. , 2001, Bioorganic & medicinal chemistry letters.
[15] F. Diederich,et al. Synthesis of Novel Nonpeptidic Thrombin Inhibitors , 2000 .
[16] N. Culeddu,et al. Enantiomerically pure pyridine and 2,2'-bipyridine thioethers: new N-S chiral ligands for asymmetric catalysis. Palladium catalyzed allylic alkylation , 1999 .
[17] K. Menear. Progress towards the discovery of orally active thrombin inhibitors. , 1998, Current medicinal chemistry.
[18] A. Naylor-Olsen,et al. Thrombin inhibitor design. , 1998, Current medicinal chemistry.
[19] Hugo Kubinyi,et al. MOLEKULARE AHNLICHKEIT. 2. STRUKTURBASIERTER ENTWURF VON WIRKSTOFFEN , 1998 .
[20] H. C. Aspinall,et al. An improved Williamson etherification of hindered alcohols promoted by 15-crown-5 and sodium hydride , 1997 .
[21] D W Banner,et al. Molecular recognition at the thrombin active site: structure-based design and synthesis of potent and selective thrombin inhibitors and the X-ray crystal structures of two thrombin-inhibitor complexes. , 1997, Chemistry & biology.
[22] F. Diederich,et al. Design of Novel, Nonpeptidic Thrombin Inhibitors and Structure of a Thrombin–Inhibitor Complex , 1995 .
[23] L. Weber,et al. DESIGN NEUARTIGER, NICHTPEPTIDISCHER THROMBIN-INHIBITOREN UND STRUKTUR EINES THROMBIN: INHIBITOR-KOMPLEXES , 1995 .
[24] Paul R. Gerber,et al. MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry , 1995, J. Comput. Aided Mol. Des..
[25] K Gubernator,et al. Design and synthesis of potent and highly selective thrombin inhibitors. , 1994, Journal of medicinal chemistry.
[26] A. Patchett,et al. Synthesis and structure-activity relationships of peptidyl alpha-keto heterocycles as novel inhibitors of prolyl endopeptidase. , 1994, Journal of medicinal chemistry.
[27] Maria Cristina Burla,et al. SIR92 – a program for automatic solution of crystal structures by direct methods , 1994 .
[28] D. Banner,et al. Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors. , 1994, The Journal of biological chemistry.
[29] S. Ley,et al. Substitution reactions of 2-phenylsulphonyl-piperidines and -pyrrolidines with carbon nucleophiles: Synthesis of the pyrrolidine alkaloids norruspoline and ruspolinone , 1991 .
[30] H. Wynberg,et al. Conformational study of cinchona alkaloids. A combined NMR and molecular orbital approach , 1990 .
[31] W. M. Davis,et al. Structural Characterization of the Pseudoenantiomeric cis-Dioxo Osmium(VI) Esters of Chiral Diols with Cinchona Alkaloid Ligands† , 1990 .
[32] K. Sharpless,et al. Strukturelle Charakterisierung pseudoenantiomerer cis‐Dioxoosmium(VI)‐Komplexe mit chiralen Diolen und Cinchona‐Alkaloid‐Liganden , 1990 .
[33] R. Huber,et al. The refined 1.9 A crystal structure of human alpha‐thrombin: interaction with D‐Phe‐Pro‐Arg chloromethylketone and significance of the Tyr‐Pro‐Pro‐Trp insertion segment. , 1989, The EMBO journal.
[34] S. Kanemasa,et al. Recent Advances in Azomethine Ylide Chemistry , 1989 .
[35] B. Furie,et al. The molecular basis of blood coagulation , 1988, Cell.
[36] R. Grigg,et al. The decarboxylative route to azomethine ylides. Mechanism of 1,3-dipole formation , 1987 .
[37] J. Hall,et al. The action of thrombin on peptide p-nitroanilide substrates. Substrate selectivity and examination of hydrolysis under different reaction conditions. , 1983, Biochimica et biophysica acta.
[38] R. Huisgen. 1,3-Dipolar cycloadditions. 76. Concerted nature of 1,3-dipolar cycloadditions and the question of diradical intermediates , 1976 .
[39] A. Pinner,et al. Umwandlung der Nitrile in Imide , 1878 .